MicroRNA-21 inhibition attenuates airway inflammation and remodelling by modulating the transforming growth factor β–Smad7 pathway
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Current asthma therapies remain unsatisfactory for controlling airway remodelling in asthma. MicroRNA-21 is a key player in asthma pathogenesis, but the molecular mechanisms underlying its effects on airway remodelling are not completely understood. We investigated the effects of inhibition of microRNA-21 on allergic airway inflammation and remodelling. Methods: Female BALB/c mice were divided into four groups: control, ovalbumin- sensitized and -challenged for 3 months, microRNA-negative control-treated ovalbumin-treated, and microRNA-21 inhibitor-treated ovalbumin-treated groups. Parameters related to airway remodelling, cytokine production, airway inflammation, and airway hyperresponsiveness were compared between groups. Human bronchial smooth muscle cells were used in a mechanism study. Results: In this asthma model, ovalbumin-sensitized and -challenged mice exhibited allergic airway inf lammation and airway remodelling. MicroRNA-21 inhibitor-treated mice had fewer inflammatory cells, lower TH2 cytokine production, and suppressed parameters related to remodelling such as goblet cell hyperplasia, collagen deposition, hydroxyproline content, and expression of smooth muscle actin. Inhibition of microRNA-21 decreased transforming growth factor β1 expression and induced Smad7 expression in lung tissue. In human bronchial smooth muscle cells stimulated with transforming growth factor β1, microRNA- 21 inhibition upregulated Smad7 expression and decreased markers of airway remodelling. Conclusions: Inhibition of microRNA-21 had both anti-inflammatory and anti-remodelling effects in this model of ovalbumin-induced chronic asthma. Our data suggest that the microRNA-21–transforming growth factor β1–Smad7 axis modulates the pathogenesis of ovalbumin-induced chronic asthma and in human bronchial smooth muscle cells. MicroRNA-21 inhibitors may be a novel therapeutic target in patients with allergic asthma, especially those with airway remodelling.
Abstract
Background/Aims: Current asthma therapies remain unsatisfactory for controlling airway remodelling in asthma. MicroRNA-21 is a key player in asthma pathogenesis, but the molecular mechanisms underlying its effects on airway remodelling are not completely understood. We investigated the effects of inhibition of microRNA-21 on allergic airway inflammation and remodelling. Methods: Female BALB/c mice were divided into four groups: control, ovalbumin- sensitized and -challenged for 3 months, microRNA-negative control-treated ovalbumin-treated, and microRNA-21 inhibitor-treated ovalbumin-treated groups. Parameters related to airway remodelling, cytokine production, airway inflammation, and airway hyperresponsiveness were compared between groups. Human bronchial smooth muscle cells were used in a mechanism study. Results: In this asthma model, ovalbumin-sensitized and -challenged mice exhibited allergic airway inf lammation and airway remodelling. MicroRNA-21 inhibitor-treated mice had fewer inflammatory cells, lower TH2 cytokine production, and suppressed parameters related to remodelling such as goblet cell hyperplasia, collagen deposition, hydroxyproline content, and expression of smooth muscle actin. Inhibition of microRNA-21 decreased transforming growth factor β1 expression and induced Smad7 expression in lung tissue. In human bronchial smooth muscle cells stimulated with transforming growth factor β1, microRNA- 21 inhibition upregulated Smad7 expression and decreased markers of airway remodelling. Conclusions: Inhibition of microRNA-21 had both anti-inflammatory and anti-remodelling effects in this model of ovalbumin-induced chronic asthma. Our data suggest that the microRNA-21–transforming growth factor β1–Smad7 axis modulates the pathogenesis of ovalbumin-induced chronic asthma and in human bronchial smooth muscle cells. MicroRNA-21 inhibitors may be a novel therapeutic target in patients with allergic asthma, especially those with airway remodelling.
참고문헌 (40)
- Saglani S, "Novel concepts in airway inflammation and remodelling in asthma", Eur Respir J, 46, pp.1796~1804 (2015)
- Boulet LP, "Airway remodeling in asthma : update on mechanisms and therapeutic approaches", Curr Opin Pulm Med, 24, pp.56~62 (2018)
- Hirota N, "Mechanisms of airway remodeling", Chest, 144, pp.1026~1032 (2013)
- Pascual RM, "Airway remodeling contributes to the progressive loss of lung function in asthma : an overview", J Allergy Clin Immunol, 116, pp.477~486 (2005)
- Bartel DP, "MicroRNAs : target recognition and regulatory functions", Cell, 136, pp.215~233 (2009)
- Lu TX, "MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression", J Immunol, 182, pp.4994~5002 (2009)
- Lu TX, "MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12", IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity, 2011, pp.187, 3362~3373
- Wu XB, "Overexpression of microRNA-21 and microRNA-126 in the patients of bronchial asthma", Int J Clin Exp Med, 7, pp.1307~1312 (2014)
- Kim RY, "MicroRNA-21drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2", J Allergy Clin Immunol, 139, pp.519~532 (2017)
- Sawant DV, "Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function", J Immunol, 189, pp.4759~4769 (2012)
- Lu TX, "Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth", PLoS One, 8, pp.e59397~ (2013)
- Vignola AM, "Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis", Am J Respir Crit Care Med, 156(2 Pt 1), pp.591~599 (1997)
- Redington AE, "Transforming growth factor-beta 1 in asthma : measurement in bronchoalveolar lavage fluid", Am J Respir Crit Care Med, 156(2 Pt 1), pp.642~647 (1997)
- Makinde T, "The regulatory role of TGF-beta in airway remodeling in asthma", Immunol Cell Biol, 85, pp.348~356 (2007)
- Tirado-Rodriguez B, "TGF-β : an important mediator of allergic disease and a molecule with dual activity in cancer development", J Immunol Res, 2014, pp.318481~ (2014)
- Kavsak P, "Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation", Mol Cell, 6, pp.1365~1375 (2000)
- Lai JY, "MicroRNA-21 in glomerular injury", J Am Soc Nephrol, 26, pp.805~816 (2015)
- Zou XZ, "MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases", Eur J Pharmacol, 796, pp.190~206 (2017)
- Lee HY, "Inhibition of MicroRNA-21by an antagomir ameliorates allergic inflammation in a mouse model of asthma", Exp Lung Res, 43, pp.109~119 (2017)
- Tarkowski M, "Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate", Am J Physiol Lung Cell Mol Physiol, 292, pp.L207~L214 (2007)
- Mabalirajan U, "Mitochondrial structural changes and dysfunction are associated with experimental allergic asthma", J Immunol, 181, pp.3540~3548 (2008)
- Hur J, "The leukotriene receptor antagonist pranlukast attenuates airway remodeling by suppressing TGF-β signaling", Pulm Pharmacol Ther, 48, pp.5~14 (2018)
- Kumarswamy R, "Regulation and function of miRNA-21 in health and disease", RNA Biol, 8, pp.706~713 (2011)
- Xie S, "Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta", Am J Physiol Lung Cell Mol Physiol, 293, pp.L245~L253 (2007)
- Zhang S, "Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation", Mol Cell Biol, 27, pp.4488~4499 (2007)
- Marts LT, "MiR-21-mediated suppression of Smad7 induces TGFβ1 and can be inhibited by activation of Nrf2 in alcohol-treated lung fibroblasts", Alcohol Clin Exp Res, 41, pp.1875~1885 (2017)
- Li X, "MicroRNA-21 promotes wound healing via the Smad7-Smad2", 3-Elastin pathway, 2018, pp.362, 245~251
- Nakagome K, "Pathogenesis of airway inflammation in bronchial asthma", Auris Nasus Larynx, 38, pp.555~563 (2011)
- Heffler E, "MicroRNA profiling in asthma : potential biomarkers and therapeutic targets", Am J Respir Cell Mol Biol, 57, pp.642~650 (2017)
- Yujia Shi, "Overexpression of miR-155-5p Inhibits the Proliferation and Migration of IL-13-Induced Human Bronchial Smooth Muscle Cells by Suppressing TGF-β-Activated Kinase 1", MAP3K7-Binding Protein 2, 2018, pp.10(3), 260~267[DOI]
- Mattes J, "Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease", Proc Natl Acad Sci U S A, 106, pp.18704~18709 (2009)
- Collison A, "Altered expression of microRNA in the airway wall in chronic asthma : miR-126 as a potential therapeutic target", BMC Pulm Med, 11, pp.29~ (2011)
- Yu ZW, "Mutual regulation between miR-21 and the TGFβ", Smad signaling pathway in human bronchial fibroblasts promotes airway remodeling, 2019, pp.56, 341~349
- Liu Y, "MiR-21 modulates human airway smooth muscle cell proliferation and migration in asthma through regulation of PTEN expression", Exp Lung Res, 41, pp.535~545 (2015)
- Liu L, "Activation of peroxisome proliferation-activated receptor-γ inhibits transforming growth factor-β1-induced airway smooth muscle cell proliferation by suppressing Smad-miR-21 signaling", J Cell Physiol, 234, pp.669~681 (2018)
- Ojiaku CA, "Transforming growth factor β1 function in airway remodeling and hyperresponsiveness. the missing link?", Am J Respir Cell Mol Biol, 56, pp.432~442 (2017)
- Halwani R, "Role of transforming growth factor-β in airway remodeling in asthma", Am J Respir Cell Mol Biol, 44, pp.127~133 (2011)
- Liu RH, "Regulatory roles of microRNA-21 in fibrosis through interaction with diverse pathways(Review)", Mol Med Rep, 13, pp.2359~2366 (2016)
- Parameswaran K, "Role of extracellular matrix and its regulators in human airway smooth muscle biology", Cell Biochem Biophys, 44, pp.139~146 (2006)
- Xie S, "Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells", Am J Physiol Lung Cell Mol Physiol, 288, pp.L68~L76 (2005)